Invitrogen CD3 Monoclonal Anti

Invitrogen CD3 Monoclonal Antibody (UCHT1), FITC, eBioscience™ 11-0038-41， 11-0038-42

数据图库

• 已发表图片 (27)
• 抗体检测数据 (1)
• 高级验证 (1)

查看全部结果图片

FIGURE 29/29

 Relative expression
This Antibody was verified by Relative expression to ensure that the antibody binds to the antigen stated.

CD3 Antibody (11-0038-42)

Staining of human peripheral blood cells. As expected based on known relative expression patterns, CD3 clone UCHT1 stains a subset of lymphocytes (T cells) and does not stain monocytes and granulocytes. Details: Normal human whole blood was surface stained with CD3 (clone UCHT1). After staining, red blood cells were lysed using 1-step Fix/Lyse Buffer. Cells in the lymphocyte (purple histogram), monocyte (or... View more



查看全部结果图片

FIGURE 28/29

CD3 Antibody (11-0038-42) in Flow

Staining of normal human peripheral blood cells with Anti-Human CD19 PE (Product # 12-0199-80) (y-axis, left) or Anti-Human CD150 PE (Product # 12-1509-42) (y-axis, right) and Anti-Human CD3 FITC (x-axis).

数据图库

• 已发表图片 (27)
• 抗体检测数据 (1)
• 高级验证 (1)

查看全部结果图片

FIGURE 1/29

CD3 Antibody (11-0038-42)

Oncoimmunology 2018 - Figure 3. Phenotype and endogenous TCR expression of CD34 + HPC-derived transgenic AR + T cells. Flow cytometric analysis of the AR-transgenic T cells. (A) CAR-transgenic GFP + cells of cultures transduced to express either the CAR:zeta or the CAR:28zeta were analyzed on day 26 of OP9-DL1 culture for CD3 and TCRalphabeta expression. As a control, GFP - cells are shown from the OP9-DL1 culture transduced to ... View more
查看全部结果图片
点击以上链接，即可跳转到BenchSci网页。免责声明
 

数据图库

• 已发表图片 (27)
• 抗体检测数据 (1)
• 高级验证 (1)

查看全部结果图片

FIGURE 2/29

CD3 Antibody (11-0038-42)

Cell research 2017 - Figure 3 Naive CD4 + T cells are converted to functional Tregs by tumor-infiltrating DCs and tumor conditioned medium (CM). (A-C) Naive CD4 + T cells from peripheral blood of patients with invasive breast carcinoma were co-cultured with or without autologous pDCs isolated from tumor (TI) or peripheral blood (PB) for 9 days in the presence or absence of 30% CM from autologous tumor slices or adjacent normal ... View more
查看全部结果图片
点击以上链接，即可跳转到BenchSci网页。免责声明

数据图库

• 已发表图片 (27)
• 抗体检测数据 (1)
• 高级验证 (1)

查看全部结果图片

FIGURE 3/29

CD3 Antibody (11-0038-42)

Cell research 2017 - Figure 6 In vivo knockdown of PITPNM3 in CD4 + T cells reverses immunosuppression and inhibits tumor progression in humanized mice. (A) Humanized mice bearing palpable MDA-MB-231 orthotopic xenografts were intraperitoneally injected daily for 14 days with PBS, 1 nmol CD4-aptamer-control siRNA (AsiC-con) or CD4-aptamer-siRNA targeting PITPNM3 (sequence in A , AsiC-PI) to assess the role of PITPNM3 in TI Treg... View more
查看全部结果图片
点击以上链接，即可跳转到BenchSci网页。免责声明
 

数据图库

• 已发表图片 (27)
• 抗体检测数据 (1)
• 高级验证 (1)

查看全部结果图片

FIGURE 4/29

CD3 Antibody (11-0038-42)

Cell research 2017 - Figure 7 CD4-aptamer-siRNA targeting PITPNM3 reduces TI Tregs and inhibits tumor progression in humanized mice with circulating human Tregs. Humanized mice, implanted with MDA-MB-231 tumors and concurrently injected intravenously with autologous Tregs, were intraperitoneally injected daily for 14 days after tumors became palpable with PBS, 1 nmol CD4-aptamer-control siRNA (AsiC-con) or CD4-aptamer-siRNA tar... View more
查看全部结果图片
点击以上链接，即可跳转到BenchSci网页。免责声明

数据图库

• 已发表图片 (27)
• 抗体检测数据 (1)
• 高级验证 (1)

查看全部结果图片

FIGURE 5/29

CD3 Antibody (11-0038-42)

Arthritis research and therapy 2016 - Published figure using CD3 monoclonal antibody (Product # 11-0038-42)
查看全部结果图片
点击以上链接，即可跳转到BenchSci网页。免责声明